KORU Medical Systems, Inc. (KRMD)
After hours:
| Previous Close | 3.2700 |
| Open | 3.2500 |
| Bid | 2.5000 x 1300 |
| Ask | 3.5900 x 800 |
| Day's Range | 3.0800 - 3.3600 |
| 52 Week Range | 1.8200 - 3.6400 |
| Volume | |
| Avg. Volume | 34,507 |
| Market Cap | 146.707M |
| Beta (5Y Monthly) | 0.35 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1310 |
| Earnings Date | Feb 28, 2023 - Mar 06, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.83 |
- Business Wire
KORU Medical Systems to Participate in the Piper Sandler 34th Annual Healthcare Conference
MAHWAH, N.J., November 21, 2022--KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients, today announced that the Company will participate in the Piper Sandler 34th Annual Healthcare Conference on December 1st, 2022.
- Business Wire
KORU Medical Systems to Participate in Upcoming Investor Conferences
MAHWAH, N.J., November 10, 2022--KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients, today announced that the Company will participate in two upcoming investor conferences.
- Business Wire
KORU Medical Systems Announces 2022 Third Quarter Financial Results
MAHWAH, N.J., November 09, 2022--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients, today reported financial results for the third quarter ended September 30, 2022.
